Failure of oral thiomalate to act as an alternative to intramuscular gold in rheumatoid arthritis.
Ten patients with active rheumatoid arthritis (RA) were entered into a pilot study to evaluate the effectiveness of thiomalic acid as a disease modifying agent and to assess its toxicity. Oral thiomalic acid (100 mg) was given daily for up to six months. Changes in disease activity were recorded mon...
Na minha lista:
| Publicado no: | Ann Rheum Dis |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1988
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1003488/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2965555/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.47.3.224 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|